1. Home
  2. COLB vs RGEN Comparison

COLB vs RGEN Comparison

Compare COLB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

COLB

Columbia Banking System Inc.

N/A

Current Price

$26.68

Market Cap

8.1B

Sector

Finance

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$119.94

Market Cap

8.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COLB
RGEN
Founded
1993
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.1B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
COLB
RGEN
Price
$26.68
$119.94
Analyst Decision
Hold
Buy
Analyst Count
14
11
Target Price
$31.32
$173.09
AVG Volume (30 Days)
2.7M
771.2K
Earning Date
04-22-2026
05-27-2026
Dividend Yield
5.49%
N/A
EPS Growth
N/A
286.96
EPS
2.30
0.86
Revenue
$177,000,000.00
$141,236,000.00
Revenue This Year
$31.85
$14.11
Revenue Next Year
$2.96
$14.71
P/E Ratio
$11.74
$141.40
Revenue Growth
18.94
35.10
52 Week Low
$19.61
$102.97
52 Week High
$32.70
$175.77

Technical Indicators

Market Signals
Indicator
COLB
RGEN
Relative Strength Index (RSI) 29.25 32.30
Support Level $25.22 $113.07
Resistance Level $27.24 $132.51
Average True Range (ATR) 0.98 6.52
MACD -0.43 -0.11
Stochastic Oscillator 7.26 6.37

Price Performance

Historical Comparison
COLB
RGEN

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: